SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 147 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 5.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,747,872 | -11.0% | 75,600 | +0.9% | 0.00% | 0.0% |
| Q2 2023 | $1,963,878 | +3.1% | 74,900 | +1.2% | 0.00% | 0.0% |
| Q1 2023 | $1,904,760 | +11.6% | 74,000 | +12.8% | 0.00% | 0.0% |
| Q4 2022 | $1,706,256 | -7.1% | 65,600 | +1.9% | 0.00% | 0.0% |
| Q3 2022 | $1,837,000 | +16.9% | 64,400 | +0.9% | 0.00% | 0.0% |
| Q2 2022 | $1,571,000 | -40.3% | 63,800 | +36.9% | 0.00% | 0.0% |
| Q1 2022 | $2,630,000 | -1.8% | 46,600 | +7.9% | 0.00% | -50.0% |
| Q4 2021 | $2,678,000 | -2.3% | 43,200 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,741,000 | -23.0% | 43,200 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $3,560,000 | +8.5% | 43,200 | -3.1% | 0.00% | 0.0% |
| Q1 2021 | $3,281,000 | +4.7% | 44,600 | +3.2% | 0.00% | 0.0% |
| Q4 2020 | $3,133,000 | +125.1% | 43,200 | +47.9% | 0.00% | +100.0% |
| Q3 2020 | $1,392,000 | +15.0% | 29,200 | +1.4% | 0.00% | 0.0% |
| Q2 2020 | $1,210,000 | – | 28,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |